AstraZeneca trial results may have included ‘outdated’ information, U.S. health officials say
Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have included “outdated information” and that could mean the company provided an incomplete view of efficacy data, U.S. federal health officials said early Tuesday.
